The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Other(J) | 105K | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 1.1M | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 317K | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 96K | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 160K | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 67K | — | $0 |
| Mar 22, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Disposed to issuer(D) | 840K | — | $0 |
| Mar 22, 2022 | Davis Todd C | Director | Other(J) | 252K | — | $0 |
| Mar 22, 2022 | Davis Todd C | Director | Disposed to issuer(D) | 86K | — | $0 |
| Mar 22, 2022 | Davis Todd C | Director | Disposed to issuer(D) | 48K | — | $0 |
| Mar 22, 2022 | Davis Todd C | Director | Disposed to issuer(D) | 23K | — | $0 |
| Mar 22, 2022 | Greenleaf Peter | Director | Other(J) | 105K | — | $0 |
| Mar 22, 2022 | Greenleaf Peter | Director | Disposed to issuer(D) | 64K | — | $0 |
| Mar 22, 2022 | Greenleaf Peter | Director | Disposed to issuer(D) | 114K | — | $0 |
| Mar 22, 2022 | Greenleaf Peter | Director | Disposed to issuer(D) | 28K | — | $0 |
| Mar 22, 2022 | Golubieski John | See Remarks | Disposed to issuer(D) | 126K | — | $0 |
| Mar 22, 2022 | Golubieski John | See Remarks | Disposed to issuer(D) | 333K | — | $0 |
| Mar 22, 2022 | Golubieski John | See Remarks | Disposed to issuer(D) | 374K | — | $0 |
| Mar 22, 2022 | Broadfin Capital, LLC | Director | Other(J) | 7.6M | — | $0 |
| Mar 22, 2022 | Broadfin Capital, LLC | Director | Disposed to issuer(D) | 86K | — | $0 |
| Mar 22, 2022 | Broadfin Capital, LLC | Director | Disposed to issuer(D) | 8K | — | $0 |
| Mar 22, 2022 | Broadfin Capital, LLC | Director | Disposed to issuer(D) | 23K | — | $0 |
| Mar 22, 2022 | Plesha Scott M. | See Remarks | Other(J) | 345K | — | $0 |
| Mar 22, 2022 | Plesha Scott M. | See Remarks | Disposed to issuer(D) | 245K | — | $0 |
| Mar 22, 2022 | Plesha Scott M. | See Remarks | Disposed to issuer(D) | 119K | — | $0 |
| Mar 22, 2022 | Plesha Scott M. | See Remarks | Disposed to issuer(D) | 348K | — | $0 |
| Mar 22, 2022 | Plesha Scott M. | See Remarks | Disposed to issuer(D) | 370K | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Other(J) | 1.2M | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Disposed to issuer(D) | 23K | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Disposed to issuer(D) | 48K | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Disposed to issuer(D) | 12K | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Disposed to issuer(D) | 48K | — | $0 |
| Mar 22, 2022 | Sirgo Mark A | Director | Disposed to issuer(D) | 86K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Other(J) | 53K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Disposed to issuer(D) | 287K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Disposed to issuer(D) | 259K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Disposed to issuer(D) | 89K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Disposed to issuer(D) | 118K | — | $0 |
| Mar 22, 2022 | Smith Thomas B | Chief Medical Officer | Disposed to issuer(D) | 130K | — | $0 |
| Mar 22, 2022 | Singh Vanila | Director | Other(J) | 36K | — | $0 |
| Mar 22, 2022 | Singh Vanila | Director | Disposed to issuer(D) | 81K | — | $0 |
| Mar 22, 2022 | Singh Vanila | Director | Disposed to issuer(D) | 48K | — | $0 |
| Mar 22, 2022 | Singh Vanila | Director | Disposed to issuer(D) | 86K | — | $0 |
| Mar 22, 2022 | Singh Vanila | Director | Disposed to issuer(D) | 17K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 282K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 83K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 269K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 91K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 30K | — | $0 |
| Mar 22, 2022 | Vollins James | See Remarks | Disposed to issuer(D) | 43K | — | $0 |
| Mar 22, 2022 | Watson W. Mark | Director | Other(J) | 91K | — | $0 |
| Mar 22, 2022 | Watson W. Mark | Director | Disposed to issuer(D) | 86K | — | $0 |
| Mar 22, 2022 | Watson W. Mark | Director | Disposed to issuer(D) | 55K | — | $0 |
| Mar 22, 2022 | Watson W. Mark | Director | Disposed to issuer(D) | 23K | — | $0 |
| Mar 9, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Option exercise(M) | 5K | — | $0 |
| Mar 9, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Option exercise(M) | 5K | — | $0 |
| Feb 11, 2022 | Broadfin Healthcare Master Fund Ltd | Director | Conversion(C) | 2.4M | $1.80 | $4.4M |
| Feb 11, 2022 | Broadfin Healthcare Master Fund Ltd | Director | Conversion(C) | 436 | $10,000.00 | $4.4M |
| Feb 4, 2022 | Vollins James | See Remarks | Tax withholding(F) | 10K | $3.66 | $36K |
| Feb 4, 2022 | Vollins James | See Remarks | Sell(S) | 19K | $3.60 | $67K |
| Jan 31, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 13K | — | $0 |
| Jan 31, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 11K | — | $0 |
| Jan 31, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 13K | — | $0 |
| Jan 31, 2022 | Vollins James | See Remarks | Option exercise(M) | 4K | — | $0 |
| Jan 31, 2022 | Vollins James | See Remarks | Option exercise(M) | 8K | — | $0 |
| Jan 31, 2022 | Vollins James | See Remarks | Option exercise(M) | 4K | — | $0 |
| Jan 31, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Jan 31, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Jan 31, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Jan 29, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 11K | — | $0 |
| Jan 29, 2022 | Vollins James | See Remarks | Option exercise(M) | 8K | — | $0 |
| Jan 29, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Jan 27, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 21K | — | $0 |
| Jan 27, 2022 | Plesha Scott M. | See Remarks | Grant(A) | 66K | — | $0 |
| Jan 27, 2022 | Plesha Scott M. | See Remarks | Grant(A) | 370K | $3.66 | $1.4M |
| Jan 27, 2022 | Plesha Scott M. | See Remarks | Option exercise(M) | 21K | — | $0 |
| Jan 27, 2022 | Vollins James | See Remarks | Option exercise(M) | 16K | — | $0 |
| Jan 27, 2022 | Vollins James | See Remarks | Grant(A) | 51K | — | $0 |
| Jan 27, 2022 | Vollins James | See Remarks | Grant(A) | 282K | — | $0 |
| Jan 27, 2022 | Vollins James | See Remarks | Option exercise(M) | 16K | — | $0 |
| Jan 27, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 17K | — | $0 |
| Jan 27, 2022 | Smith Thomas B | Chief Medical Officer | Option exercise(M) | 17K | — | $0 |
| Jan 27, 2022 | Smith Thomas B | Chief Medical Officer | Grant(A) | 259K | $3.66 | $949K |
| Jan 27, 2022 | Smith Thomas B | Chief Medical Officer | Grant(A) | 46K | — | $0 |
| Jan 27, 2022 | Golubieski John | See Remarks | Grant(A) | 374K | $3.66 | $1.4M |
| Jan 27, 2022 | Golubieski John | See Remarks | Grant(A) | 67K | — | $0 |
| Jan 27, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Grant(A) | 205K | — | $0 |
| Jan 27, 2022 | Bailey Jeffrey Allen | Chief Executive Officer, Director | Grant(A) | 1.1M | $3.66 | $4.2M |
| Jan 27, 2022 | Greenleaf Peter | Director | Option exercise(M) | 10K | — | $0 |
| Jan 27, 2022 | Greenleaf Peter | Director | Option exercise(M) | 10K | — | $0 |
| Jan 27, 2022 | Greenleaf Peter | Director | Grant(A) | 20K | — | $0 |
| Jan 27, 2022 | Greenleaf Peter | Director | Grant(A) | 114K | $3.66 | $419K |
| Jan 27, 2022 | Broadfin Capital, LLC | Director | Option exercise(M) | 8K | — | $0 |
| Jan 27, 2022 | Broadfin Capital, LLC | Director | Grant(A) | 86K | — | $0 |
| Jan 27, 2022 | Broadfin Capital, LLC | Director | Option exercise(M) | 8K | — | $0 |
| Jan 27, 2022 | Broadfin Capital, LLC | Director | Grant(A) | 15K | — | $0 |
| Jan 27, 2022 | Sirgo Mark A | Director | Option exercise(M) | 8K | — | $0 |
| Jan 27, 2022 | Sirgo Mark A | Director | Option exercise(M) | 8K | — | $0 |
| Jan 27, 2022 | Sirgo Mark A | Director | Grant(A) | 86K | — | $0 |
| Jan 27, 2022 | Sirgo Mark A | Director | Grant(A) | 15K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).